GEMLOQ Trademark

Trademark Overview


On Monday, April 22, 2024, a trademark application was filed for GEMLOQ with the United States Patent and Trademark Office. The USPTO has given the GEMLOQ trademark a serial number of 98512645. The federal status of this trademark filing is REGISTERED as of Tuesday, February 24, 2026. This trademark is owned by Gemini Pharmaceuticals, Inc.. The GEMLOQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Authentication of data in the field of documents and personal records using blockchain technology; Providing temporary use of on-line non-downloadable software for accessing, reading, and tracking information in the field of pharmaceuticals, dietary supplements and food manufacturing on a blockchain; Software as a service (SAAS) services featuring software for data authentication via blockchain
gemloq

General Information


Serial Number98512645
Word MarkGEMLOQ
Filing DateMonday, April 22, 2024
Status700 - REGISTERED
Status DateTuesday, February 24, 2026
Registration Number8153195
Registration DateTuesday, February 24, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesAuthentication of data in the field of documents and personal records using blockchain technology; Providing temporary use of on-line non-downloadable software for accessing, reading, and tracking information in the field of pharmaceuticals, dietary supplements and food manufacturing on a blockchain; Software as a service (SAAS) services featuring software for data authentication via blockchain

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 22, 2024
Primary Code042
First Use Anywhere DateTuesday, February 27, 2024
First Use In Commerce DateTuesday, February 27, 2024

Trademark Owner History


Party NameGemini Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCommack, NY 11725
US

Party NameGemini Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCommack, NY 11725
US

Party NameGemini Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCommack, NY 11725
US

Trademark Events


Event DateEvent Description
Monday, April 22, 2024NEW APPLICATION ENTERED
Monday, April 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 5, 2024ASSIGNED TO EXAMINER
Wednesday, November 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 10, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, January 15, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 10, 2025USE AMENDMENT FILED
Tuesday, January 20, 2026STATEMENT OF USE PROCESSING COMPLETE
Saturday, January 31, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, January 31, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 24, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, February 24, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED